Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning (2019)
- Authors:
- Autor USP: NOUSHMEHR, HOUTAN - FMRP
- Unidade: FMRP
- DOI: 10.1093/neuonc/noz175.558
- Subjects: ENSAIO CLÍNICO; MENINGIOMA; GLÂNDULA PITUITÁRIA; NEOPLASIAS CEREBRAIS; ASTROCITOMA
- Language: Inglês
- Imprenta:
- Publisher: Society for Neuro-Oncology
- Publisher place: Oxford
- Date published: 2019
- Source:
- Título: Neuro-oncology
- ISSN: 1522-8517
- Volume/Número/Paginação/Ano: v. 21, suppl. 6, res. INNV-15, p. vi133, 2019
- Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SNYDER, James et al. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.558. Acesso em: 19 fev. 2026. , 2019 -
APA
Snyder, J., Wells, M., Poisson, L., Kalkanis, S., Noushmehr, H., & Robin, A. (2019). Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.558 -
NLM
Snyder J, Wells M, Poisson L, Kalkanis S, Noushmehr H, Robin A. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning [Internet]. Neuro-oncology. 2019 ; 21 vi133.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1093/neuonc/noz175.558 -
Vancouver
Snyder J, Wells M, Poisson L, Kalkanis S, Noushmehr H, Robin A. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning [Internet]. Neuro-oncology. 2019 ; 21 vi133.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1093/neuonc/noz175.558 - TCGA workflow: analyze cancer genomics and epigenomics data using bioconductor packages [version 2; referees: 1 approved, 2 approved with reservations]
- The cancer genome atlas pan-cancer analysis project
- The somatic genomic landscape of glioblastoma
- Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1
- Mais um passo da ciência. [Depoimento a Rosemeire Soares Talamone]
- Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs
- GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
- Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31
- Molecular patterns at regulatory elements diferentially methylated in glioma
- DNA methylation signature associated with risk of recurrence in papillary thyroid carcinoma
Informações sobre o DOI: 10.1093/neuonc/noz175.558 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
